Highlighted Publications

Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.

Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, Kotler G, Lee IM, Manson JE, Costenbader KH. BMJ. 2022 Jan 26;376:e066452. doi: 10.1136/bmj-2021-066452. PMID: 35082139.

Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center’s Experience With 400 Patients

Emma Stevens BA Michael E. Weinblatt MD Elena Massarotti MD Frances Griffin RN Srinivas Emani PhD Sonali Desai MD, MPH. ACR Open Rheumatol. 2020 Jun; 2(6): 357-361. PMID: 32412669

Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis.

Rao DA, Arazi A, Wofsy D, Diamond B. Nat Rev Nephrol. 2020 Apr;16(4):238-250. doi: 10.1038/s41581-019-0232-6. Epub 2019 Dec 18. PMID: 31853010 Free PMC article. Review.

Racial Differences in Contraception Encounters and Dispensing Among Female Medicaid Beneficiaries with Systemic Lupus Erythematosus

Williams JN, Xu C, Costenbader KH, Bermas BL, Pace LE, Feldman CH. Arthritis Care Res (Hoboken). 2020 Jun 11. PMID: 32526084.

Ass ociation of Childhood Abuse with Incident Systemic Lupus Erythematosus in Adulthood in a Longitudinal Cohort of Women.
Feldman CH, Malspeis S, Leatherwood C, Kubzansky L, Costenbader KH, Roberts AL. J Rheumatol. 2019 May 15. PMID: 31092723.

Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.
Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH. Rheumatology (Oxford). 2019 Jul 18. PMID: 31321417.

PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.

Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, Muise ES, Zhang KX, Arazi A, Keras G, Li ZJ, Qu Y, Gurish MF, Petri M, Buyon JP, Putterman C, Wofsy D, James JA, Guthridge JM, Diamond B, Anolik JH, Mackey MF, Alves SE, Nigrovic PA, Costenbader KH, Brenner MB, Lederer JA, Rao DA; Accelerating Medicines Partnership (AMP) RA/SLE Network. JCI Insight. 2019 Oct 17;4(20):e130062. doi: 10.1172/jci.insight.130062.

The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A*, Rao DA*, Berthier CC*, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall’Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network. Nat Immunol. 2019 Jul;20(7):902-914. doi: 10.1038/s41590-019-0398-x. Epub 2019 Jun 17. * co-first authors.

Cell-bound complement activation products associate with lupus severity in SLE

Cristina Arriens ,1,2 Roberta Vezza Alexander, Sonali Narain, Amit Saxena, Christopher E Collins, Daniel J Wallace, Elena Massarotti, John Conklin, Kenneth C Kalunian, Chaim Putterman, Rosalind Ramsey-Goldman,
Jill P Buyon, Anca Askanase, Richard A Furie, Judith A James,
Ghalib A Bello,Susan Manzi, Joseph Ahearn,Tyler O’Malley , Arthur Weinstein, Thierry Dervieux. Cell-bound complement activation products associate with lupus severity in SLELupus Science & Medicine 2020;7:e000377. doi: 10.1136/lupus-2019-000377.

Area-Level Predictors of Medication Nonadherence Among US Medicaid Beneficiaries With Lupus: A Multilevel Study.
Feldman CH, Costenbader KH, Solomon DH, Subramanian SV, Kawachi Arthritis Care Res (Hoboken). 2019 Jul; 71(7):903-913.PMID: 30055088.

Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies.
Leatherwood C, Speyer CB, Feldman CH, D’Silva K, Gómez-Puerta JA, Hoover PJ, Waikar SS, McMahon GM, Rennke HG, Costenbader KH. Semin Arthritis Rheum. 2019 Jun 11. PMID: 31277928.

Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients.
Chen SK, Barbhaiya M, Fischer MA, Guan H, Yoshida K, Feldman CH, Costenbader KH, Everett BM. Semin Arthritis Rheum. 2019 Jun 11. PMID: 31280938.

Time to progression from discoid lupus erythematosus (DLE) to systemic lupus erythematosus (SLE): a retrospective cohort study.
Elman SA, Joyce C, Costenbader KH, Merola JF. Clin Exp Dermatol. 2019 May 23. PMID: 31120600.

Relationship of Cigarette Smoking and Alcohol Consumption to Incidence of Systemic Lupus Erythematosus in a Prospective Cohort Study of Black Women.
Cozier YC, Barbhaiya M, Castro-Webb N, Conte C, Tedeschi SK, Leatherwood C, Costenbader KH, Rosenberg L. Arthritis Care Res (Hoboken). 2019 May; 71(5):671-677. PMID: 30091287.

Comparative Fracture Risks among US Medicaid Enrollees with and without Systemic Lupus Erythematosus.
Tedeschi SK, Kim SC, Guan H, Grossman JM, Costenbader KH. Arthritis Rheumatol. 2019 Feb 04. PMID: 30714690.

A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M, Costenbader KH, Johnson SR, Lorenzoni V, Sebastiani GD, Hoyer BF, Navarra S, Bonfa E, Ramsey-Goldman R, Medina-Rosas J, Piga M, Tani C, Tedeschi SK, Dörner T, Aringer M, Touma Z. Arthritis Rheumatol. 2019 Jan; 71(1):91-98. PMID: 30035365.

Lipid Testing and Statin Prescriptions Among Medicaid Recipients With Systemic Lupus Erythematosus or Diabetes Mellitus and the General Medicaid Population.
Chen SK, Barbhaiya M, Fischer MA, Guan H, Lin TC, Feldman CH, Everett BM, Costenbader KH. Arthritis Care Res (Hoboken). 2019 Jan; 71(1):104-115. PMID: 29648687.

Association of Depression With Risk of Incident Systemic Lupus Erythematosus in Women Assessed Across 2 Decades.
Roberts AL, Kubzansky LD, Malspeis S, Feldman CH, Costenbader KH. JAMA Psychiatry. 2018 Dec 01; 75(12):1225-1233. PMID: 30208373.

Pesticide exposure and risk of systemic lupus erythematosus in an urban population of predominantly African-American women.
Williams JN, Chang SC, Sinnette C, Malspeis S, Parks CG, Karlson EW, Fraser P, Costenbader K. . Lupus. 2018 Nov; 27(13):2129-2134. PMID: 30309287.

Sex Differences in Health Care Utilization, End-Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis.
Feldman CH, Broder A, Guan H, Yazdany J, Costenbader KH. . Arthritis Rheumatol. 2018 Mar; 70(3):417-426. PMID: 29193893.

Cigarette smoking and the pathogenesis of systemic lupus erythematosus.
Speyer CB, Costenbader KH. Expert Rev Clin Immunol. 2018 June; 14(6):481-487. PMID: 29724134.

Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs.
Feldman CH, Liu J, Feldman S, Solomon DH, Kim SC. Lupus. 2017 Jun;26(7):682-689. PMID: 27799438

Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?
Massarotti EM, Allore HG, Costenbader K. Arthritis Rheumatol. 2017 Feb; 69(2):245-248. PMID: 27860434.

Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration.
Tedeschi SK, Johnson SR, Boumpas D, Daikh D, Dörner T, Jayne D, Kamen D, Lerstrøm K, Mosca M, Ramsey-Goldman R, Sinnette C, Wofsy D, Smolen JS, Naden RP, Aringer M, Costenbader KH. Arthritis Care Res (Hoboken). 2017 Jul 10. PMID: 28692774.

Can Patient Navigators Improve Adherence to Disease-Modifying Antirheumatic Drugs? Quantitative Findings from the Med Assist Pilot Study.
Feldman CH, Wohlfahrt A, Campos A, Gagne JJ, Iversen MD, Massarotti E, Solomon DH, Kawachi I. . Arthritis Care Res (Hoboken). 2017 Jun 02. PMID: 28575545.